Data

Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Study Number Title Investigator(s) Release Date Sort descending
CTN NIDA-CTN-0049 Project HOPE - Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users Lisa Metsch, Ph.D., Carlos del Rio, M.D. Sep 07, 2018
DTMC NIDA-CTO-0012 Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence Eugene Somoza, M.D. Jan 15, 2019
DTMC NIDA-CTO-0011 Double-Blind, Placebo-Controlled, Dose Response Trial Of Ondansetron For The Treatment Of Methamphetamine Dependence Bankole Johnson, DSc., M.D., Ph.D. Jan 15, 2019
GRNT NIDA-CENIC-P1S1 Investigating the Impact of Nicotine Using Spectrum Cigarettes (P1S1) - Grant U54-DA031659 Eric C. Donny, Ph.D. Feb 14, 2020
DTMC NIDA-CPU-0010 Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine Louis Cantilena, Jr., M.D, Ph.D. Jun 03, 2020
CTN NIDA-CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) Walter Ling, M.D. Oct 09, 2020
CTN NIDA-CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) Madhukar H. Trivedi, M.D. Oct 07, 2022
DTMC NIDA-CPU-0011 Ph1 Marinol Interaction Study - Part 1 Louis Cantilena, Jr., M.D, Ph.D. Nov 30, 2022
CTN NIDA-CTN-0075 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder Li-Tzy Wu, Psy.D., Paolo Mannelli, MD Feb 16, 2023
CTN NIDA-CTN-0093 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool Gerald Cochran, PhD, T. John Winhusen, Ph.D. Apr 13, 2023